跳至主要内容
临床试验/EUCTR2015-005086-23-SE
EUCTR2015-005086-23-SE进行中(未招募)1 期

Mekobalamin's (Vitamin B12) effect on long-term pain in women with fibromyalgi.

innéuniversitetet0 个研究点目标入组 40 人开始时间: 2018年4月20日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • *Swedish speaking women between 20-70 years
  • *Diagnosed with fibromyalgia
  • *Conscent to the trial
  • * Use a safe birth control method such as birth control pills, p-rod, p-syringe, p-patch, hormone coil, copper coil
  • *-Renal function value
  • GFR >60 mL/min/1,73 m2
  • *Liver function value:
  • P-ALP 0,6-2,85 µkat/L
  • P-ALAT 0,15-1,13 µkat/L
  • *Cardiac function value
  • Troponin-T < 15 ng/L
  • NT-pro-BNP >125 <450 <50 years
  • NT-pro-BNP >300 <900 50-75 years
  • *Kobalamin >250 pmol/L < 800 pmol/L
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 35
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 5

排除标准

  • *use of neuroleptics (antipsychotic treatment)
  • *have Reynaud's phenomenon (white finger)
  • * neuropathi (numbness)
  • *previous treatment with Vitamin B12
  • *cardiac, hepatic or renal impairment
  • *hypersensitivity to the active substance or any of the excipients
  • *pregnant or planning to become pregnant
  • *breast feeding

研究者

发起方
innéuniversitetet

相似试验